JPS5742615A - - Google Patents

Info

Publication number
JPS5742615A
JPS5742615A JP56110980A JP11098081A JPS5742615A JP S5742615 A JPS5742615 A JP S5742615A JP 56110980 A JP56110980 A JP 56110980A JP 11098081 A JP11098081 A JP 11098081A JP S5742615 A JPS5742615 A JP S5742615A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56110980A
Other versions
JPH0148885B2 (ja
Inventor
Maabin Jiyoonzu Toreboo
Robaato Howaito Aran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS5742615A publication Critical patent/JPS5742615A/ja
Publication of JPH0148885B2 publication Critical patent/JPH0148885B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
JP56110980A 1980-07-18 1981-07-17 Expired JPH0148885B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18

Publications (2)

Publication Number Publication Date
JPS5742615A true JPS5742615A (ja) 1982-03-10
JPH0148885B2 JPH0148885B2 (ja) 1989-10-20

Family

ID=10514892

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56110980A Expired JPH0148885B2 (ja) 1980-07-18 1981-07-17

Country Status (6)

Country Link
US (1) US4963555A (ja)
JP (1) JPH0148885B2 (ja)
KR (1) KR830005852A (ja)
GE (1) GEP19981256B (ja)
SU (1) SU1375113A3 (ja)
ZA (1) ZA814925B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503695A (ja) * 1990-01-26 1993-06-17 ビーチャム　グループ　ピーエルシー 医薬製剤

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
AU2004270258A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
AU2006223136A1 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxycarboxylic acids
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
BRPI0608690B8 (pt) 2005-03-10 2021-05-25 3M Innovative Properties Co uso de uma composição antimicrobiana
WO2007133944A2 (en) * 2006-05-09 2007-11-22 Emisphere Technologies, Inc. Topical administration of acyclovir
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
US8853223B2 (en) * 2010-09-17 2014-10-07 G2L Touch, Inc. Therapeutic composition to treat lesions caused by herpes simplex virus
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
RU2457843C1 (ru) * 2011-05-11 2012-08-10 Общество с ограниченной ответственностью фирма "Вита" Стабилизированный фармацевтический состав с противовирусным действием
WO2013077881A1 (en) 2011-11-23 2013-05-30 3B Pharmaceuticals, Inc. Antiviral formulations
WO2017011785A1 (en) 2015-07-15 2017-01-19 National Concessions Group Inc. Topical antiviral formulations and methods of using the same
DK3638251T3 (da) * 2017-06-12 2024-05-13 Lakewood Amedex Inc Bisphosphocin gel formuleringer og brug deraf
CA3142831A1 (en) 2019-06-14 2020-12-17 Propella Therapeutics, Inc. Topical acyclovir formulations and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52105195A (en) * 1976-03-01 1977-09-03 Wellcome Found Substituted purine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536816A (en) * 1964-09-30 1970-10-27 Atlas Chem Ind Water-in-oil emulsion
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
CH558659A (fr) * 1969-11-26 1975-02-14 Orsymonde Procede pour la preparation d'une composition lyophilisee a usage hygienique.
US3924004A (en) * 1971-11-24 1975-12-02 Syntex Corp Fatty alcohol-propylene carbonate-glycol solvent cream vehicle
ZA72698B (en) * 1972-02-03 1973-09-26 Liebenberg R W Method of preparing medicinal compositions
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US3867528A (en) * 1973-10-11 1975-02-18 American Cyanamid Co Steroidal topical cream base
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4144332A (en) * 1976-01-05 1979-03-13 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
SE7702990L (sv) * 1976-03-19 1977-09-20 Minnesota Mining & Mfg Tropiskt administreringssystem for lekemedel med forsterkt peutreringsformaga
DE2646435B2 (de) * 1976-10-14 1979-05-31 Shiseido Co., Ltd., Tokio Verfahren zur Herstellung einer stabilen Öl-in-Wasser-Emulsion
GB1556632A (en) * 1977-01-14 1979-11-28 Sterling Drug Inc Antimicrobial skin cleasing composition
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
CA1113005A (en) * 1977-12-06 1981-11-24 Pierluigi Vanoni Excipient composition for creams
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52105195A (en) * 1976-03-01 1977-09-03 Wellcome Found Substituted purine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503695A (ja) * 1990-01-26 1993-06-17 ビーチャム　グループ　ピーエルシー 医薬製剤

Also Published As

Publication number Publication date
SU1375113A3 (ru) 1988-02-15
GEP19981256B (en) 1998-04-01
ZA814925B (en) 1983-02-23
JPH0148885B2 (ja) 1989-10-20
US4963555A (en) 1990-10-16
KR830005852A (ko) 1983-09-14

Similar Documents

Publication Publication Date Title
FR2473414B1 (ja)
FR2473245B1 (ja)
FR2473056B1 (ja)
JPS5742615A (ja)
FR2474256B1 (ja)
FR2473243B1 (ja)
FR2474624B1 (ja)
FR2475425B1 (ja)
FR2475047B1 (ja)
FR2475435B1 (ja)
FR2475303B1 (ja)
FR2473183B1 (ja)
FR2474630B1 (ja)
FR2473546B3 (ja)
FR2475220B1 (ja)
FR2474418B1 (ja)
FR2474366B1 (ja)
FR2473618B1 (ja)
JPS56149474U (ja)
FR2475095B1 (ja)
FR2474367B3 (ja)
FR2474612B1 (ja)
FR2474590B1 (ja)
FR2473485B3 (ja)
FR2474645B1 (ja)